Aims/hypothesis Insulin effects reportedly involve reactive oxygen species (ROS) and oxidative stress in vitro, but skeletal muscle oxidative stress is an emerging negative regulator of insulin action following high-fat feeding. NEFA may enhance oxidative stress and insulin resistance. We investigated the acute impact of insulin with or without NEFA elevation on muscle ROS generation and insulin signalling, and the potential association with altered muscle mitochondrial function. Methods We used hyperinsulinaemic-euglycaemic clamping, 150 min, without or with lipid infusion to modulate plasma NEFA concentration in lean rats. Results Insulin and glucose (Ins) infusion selectively enhanced xanthine oxidase-dependent muscle ROS generation. Ins with lipid infusion (Ins+NEFA) lowered whole-body glucose disposal and muscle insulin signalling, and these effects were associated with high muscle mitochondrial ROS generation and activation of the proinflammatory nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) pathway. Antioxidant infusion prevented NEFA-induced systemic insulin resistance and changes in muscle mitochondrial ROS generation, IκB-NFκB pathway and insulin signalling. Changes in insulin sensitivity and signalling were independent of changes in mitochondrial enzyme activity and ATP production, which, in turn, were not impaired by changes in ROS generation under any condition. Conclusions/interpretation Acute muscle insulin effects include enhanced ROS generation through xanthine oxidase. Additional NEFA elevation enhances mitochondrial ROS generation, activates IκB-NFκB and reduces insulin signalling. These alterations are not associated with acute reductions in mitochondrial enzyme activity and ATP production, and are reversed by antioxidant infusion. Thus, NEFA acutely cause systemic and muscle insulin resistance by enhancing muscle oxidative stress through mitochondrial ROS generation and IκB-NFκB activation.
Introduction
Insulin has been shown to enhance reactive oxygen species (ROS) generation and oxidative stress in adipose and liver cells in vitro, and these effects are reported to be directly involved in the stimulation of insulin signalling by inactivation of protein phosphatases [1] [2] [3] . A more recent study also found that mice lacking the major antioxidant enzyme glutathione peroxidase have high muscle oxidative stress and are less, rather than more, insulin resistant than wild-type counterparts [4] . In contrast with the above observations, oxidative stress markers are elevated in insulin-resistant obese and type 2 diabetic individuals [3, 5, 6] , and oxidative stress is reported to occur in, and directly contribute to, fatinduced insulin resistance in skeletal muscle in high-fat-fed rodents [7] . Available data also indicate that oxidativestress-induced insulin resistance involves nuclear factor-κB (NFκB) nuclear translocation after nuclear factor-κB inhibitor α (IκBα) phosphorylation and degradation [8] . The potential involvement of chronic NEFA elevation in highfat-diet-induced changes in muscle oxidative stress, inflammation and insulin action is suggested by in vitro studies [9, 10] , and fatty acids are also reported to induce insulin resistance in vivo [11, 12] . In addition, the onset of oxidative stress and inflammation during chronic high-fat or highenergy feeding has been reported to lower skeletal muscle mitochondrial oxidative capacity [13, 14] , and this alteration could contribute to insulin resistance through impaired muscle lipid oxidation [15] . The in vivo effects of NEFA on muscle oxidative stress, inflammation and mitochondrial function as well as the potential pathways involved and their associations with insulin signalling remain, however, undefined.
In the current study we sought to determine the potential interactions between insulin and NEFA in the regulation of muscle ROS generation and insulin sensitivity in vivo. The impact of physiological insulin elevation on muscle ROS generation from different mitochondrial and nonmitochondrial sources was investigated using the hyperinsulinaemic-euglycaemic clamp technique. The potential additional impact of concomitant NEFA elevation on muscle ROS generation, the ROS-activated IκB-NFκB proinflammatory pathway and insulin action was also investigated in the presence and absence of antioxidants. Parallel changes in muscle mitochondrial function were determined in order to assess their response to acute changes in tissue redox state and their potential association with changes in insulin sensitivity.
Methods

Animals and experimental protocol
The experimental protocol was approved by the Committee for Animal Studies at Trieste University. Seventy 12-weekold male Wistar rats were purchased from Harlan-Italy (San Pietro al Natisone, Udine, Italy) and kept for 2 weeks in the Animal Facility of the University of Trieste in individual cages with a 12 h light-dark cycle (06:00 hours/ 18:00 hours). Starting 3 days before the experiments, 4 h tail-restraint periods were performed each day [16] by pulling the tail through a tail-sized hole in the cage and securing it to a horizontal Plexiglass support. Animals had free access to water and standard rat chow (Harlan 2018, 14.2 kJ/g, Harlan, San Pietro al Natisone, Italy). To minimise potential stress responses and eliminate any differential response among groups, identical restraining training and study protocols were applied to all animal groups. No significant changes in blood glucose, a relevant stress marker, were observed following the 4 h adaptation periods (data not shown).
On the morning of the infusion day, catheters were placed percutaneously into one tail vein and one tail artery under local lidocaine anaesthesia [16] , and the tail was then secured as described above. Food was withdrawn after catheter placement and animals were kept in this position for 4 h before the infusions were started. Immediately before the start of infusions (t00), 250 μl blood samples were drawn from the artery for basal measurements of blood glucose (Accu-Chek, Roche Diagnostic Corporation, Indianapolis, IN, USA) or stored at −80°C for measurement of insulin and NEFA. Rats were randomly assigned to undergo one of the following 150 min infusion protocols: (1) control, NaCl infusion (n018); (2) Superoxide anion generation Cellular superoxide anion production systems in gastrocnemius lateralis muscle homogenate were assayed combining specific substrates and inhibitors for each source. Detection was performed using the lucigenin chemiluminescence method [19] . Lucigenin concentration in the assay was 10 μmol/l to prevent redox cycling. Briefly, freshly isolated tissue was cleaned of connective tissue and homogenised in ice-cold Krebs-HEPES buffer (20 mmol/l HEPES, pH07.4, 99 mmol/l NaCl, 4.7 mmol/l KCl, 1.2 mmol/l MgSO 4 , 1 mmol/l KH 2 PO 4 , 1.9 mmol/l CaCl 2 , 25 mmol/l NaHCO 3 , 11 mmol/l D-glucose) with protease inhibitors (Sigma). After centrifugation to remove insoluble debris (240×g, 15 min, 4°C), the suspension was diluted in Krebs-HEPES buffer and lucigenin was added. An 180 μl volume of the mixture was rapidly transferred to a white 96-well microplate (Nunc). Each well already contained 20 μl of either ultrapure H 2 O for sample basal superoxide measurement or the superoxide scavenger tiron (10 mmol/l) as a negative control and, to test single sources: xanthine (500 μmol/l) with or without the inhibitor oxypurinol (200 μmol/l); NADPH (1 mmol/l) with or without the inhibitor diphenyleneiodonium (200 μmol/l); the cyclo-oxygenase inhibitor indometacin (100 μmol/l); or the mitochondrial uncoupler CCCP (5 μmol/l). In pilot experiments the concentrations for all substrates and inhibitors were tested, and did not alter luminescence in the absence of cellular homogenate. During incubation at 37°C , from 10 to 30 min, light emission was monitored every 6 s in a microplate luminometer (Sinergy2, BioTek Instruments, Winooski, VT, USA). To ensure all measurements related to superoxide production, a subsequent reading was performed after addition of tiron to all wells. Samples were run in duplicate. The results were calculated for each well by integration of single light-emission measurements and normalised by protein content in the sample (BCA assay, Pierce). For each source, relative superoxide production was assumed as the difference between basal or, when available, substrate-stimulated production values and the values obtained with the addition of the specific inhibitor.
Glutathione Glutathione is the major buffering system for scavenging ROS, and a shift towards its oxidised form reflects a more oxidised tissue redox state [7] . Total and oxidised glutathione (GSSG) levels were determined in tissue homogenates using the HT Glutathione Assay Kit (Trevigen, Gaithersburg, MD, USA). Briefly,~50 mg of the gastrocnemius sample was cleaned and homogenised in ice-cold 5% (wt/vol.) metaphosphoric acid (20 ml/g tissue). Homogenates were then centrifuged (12,000×g for 15 min) and the supernatant fraction was used for total glutathione measurement after appropriate dilution. For oxidised glutathione, samples were pretreated with 2 mol/l 4-vinylpyridine. Total and GSSG were then measured using the reagents and calibration set provided by the HT Glutathione Assay Kit. Reduced glutathione (GSH) was calculated by subtracting the oxidised fraction from the total.
Protein analysis Total tissue protein was extracted from homogenised tissue as described [20] . Protein concentrations in all samples were measured by spectrophotometer (BCA Protein Assay Reagent, Pierce, Rockford, IL, USA). Total v-akt murine thymoma viral oncogene homologue 1 (AKT), phospho(Ser473)-AKT, total IκBα and phospho (Ser32)-IκBα were measured by western blotting using commercially available antibodies (Cell Signaling Technology, Beverly, MA, USA) [20] . Individual results were expressed as percentages of the average values in the control group.
Electrophoretic mobility shift assay Nuclei from rat muscle were prepared with a modified version of previously described methods [21] . Tissue samples were homogenised in a buffered sucrose-salt solution (0.2 mmol/l K 2 HPO 4 , 0.6 mmol/l KH 2 PO 4 , 0.32 mol/l sucrose, 1 mmol/l MgCl 2 , pH06.8) with protease inhibitors (Sigma), nuclei were collected by centrifugation (800×g, 5 min, 4°C) and washed with the same procedure. Myofibrils and mitochondria were removed by prolonged high-speed centrifugation (16,000×g, 90 min, 4°C) after resuspension in high-sucrose buffer (0.2 mmol/l K 2 HPO 4 , 0.6 mmol/l KH 2 PO 4 , 2.15 mol/l sucrose, 1 mmol/l MgCl 2 , pH06.8). Isolated nuclei were resuspended in PBS, pH07.4. Protein content was measured by standard BCA assay (Pierce). Complementary 3′-biotinylated synthetic oligonucleotides containing a high-affinity consensus sequence for NFκB (forward: 5′-AGTTGAGGG GACTTTCCCAGGC-3′-biotin) were annealed by dilution (50 mmol/l Tris, pH 8.0, 100 mmol/l NaCl), heating to 95°C for 4 min and subsequent thermal downramping (0. 
Mitochondrial function
Cytochrome c oxidase and citrate synthase activities Cytochrome c oxidase and citrate synthase enzyme activities were measured spectrophotometrically from tissue homogenates as described previously [22] .
ATP synthesis ATP synthesis rate was measured on freshly isolated mitochondria as described [23] , with slight modifications. Mitochondria were isolated by differential centrifugation as described for the mitochondrial ROS assay, except that buffers A (50 mmol/l Tris, pH 7.2, 100 mmol/l KCl, 5 mmol/l MgCl 2 , 1.8 mmol/l ATP, 1 mmol/l EDTA) and B (225 mmol/l sucrose, 44 mmol/l KH 2 PO 4 , 12.5 mmol/l Mg (CH 3 COO) 2 , 6 mmol/l EDTA) were used in place of SH and R. The efficiency of purification and mitochondrial integrity were confirmed by citrate synthase assays on isolation fractions. Concentrated respiration substrates had been prepared previously, aliquoted and frozen at −80°C. Their composition and final reaction concentrations were: 0.25 mmol/l pyruvate, 12.5 μmol/l palmitoyl-L-carnitine, 2.5 mmol/l α-ketoglutarate, 0.25 mmol/l malate (PPKM); 25 μmol/l palmitoyl-L-carnitine, 0.5 mmol/l malate (PCM); 20 mmol/l succinate, 0.1 mmol/l rotenone (SR); and 10 mmol/l glutamate, 5 mmol/l malate (GM). The ATP synthesis rate was assayed by kinetic measurement of light emission from each well (interval 2 min, integration time 1 s) using a microplate luminometer (Synergy 2 SL, BioTek). Each well contained 25 μl of diluted sample or ATP standard (50-0 μmol/l) in buffer B, 25 μl of substrate (PCM, PPKM, SR or GM) and 175 μl of assay buffer containing luciferin and luciferase (ATP Reagent SL; BioThema, Handen, Sweden). Finally, 25 μl of ADP l mmol/l, previously cleared from ATP contamination by glucose/hexokinase incubation, were added in each well to start state 3 respiration. All samples were run in duplicate. 250 μg of oligomycin was added to some wells to verify that ATP was generated from mitochondrial respiration. The luciferase-related ATP decrease rate was calculated from standards and used to correct measurement slopes. ATP synthesis rate was then calculated by interpolation of the light emission per min in the linear phase with the ATP standard curve. Measurements obtained were normalised by protein concentration in the mitochondrial fraction preparation, as measured by BCA protein assay (Pierce) and expressed as μmol (mg protein)
Plasma insulin and NEFA Plasma insulin concentration was measured by radioimmunoassay using a commercially available kit (Linco, St Louis, MO, USA). Plasma NEFA were determined spectrophotometrically (NEFA-C; WAKO Pure Chemical Industries, Osaka, Japan).
Statistical analysis Results in the four groups were compared using one-way ANOVA. Post hoc tests were then used to compare the results of two groups. The paired Student's t test was used to compare results before and following infusions. A p value of <0.05 was considered statistically significant.
Results
Body weight and plasma metabolic profile
Body weights were comparable in the four experimental groups (control 320±5 g; Ins 314±2 g; Ins+NEFA 316±5 g; Ins+NEFA+NAC 320±4 g). Blood glucose, plasma insulin and NEFA levels were comparable in all groups under basal conditions. The increases in plasma insulin were comparable in the Ins, Ins+NEFA and Ins+NEFA+NAC groups following infusions, while remaining stable in the NaCl-infused control animals (Fig. 1a) . No significant differences in blood glucose were observed throughout the study, by design (Fig. 1b) . Plasma NEFA levels were not modified by NaCl, but were reduced with Ins as expected. In contrast, lipid infusions with Ins+NEFA and Ins+NEFA+NAC induced similar NEFA elevations compared with both basal and post-infusion values in the control and Ins groups (Fig. 1c) .
Insulin-mediated glucose disposal and skeletal muscle insulin signalling
Glucose infusion rate during insulin infusion, normalised for time and body weight, reflects whole-body insulin-stimulated glucose disposal and is therefore an accurate index of insulin sensitivity. Insulin sensitivity at the whole-body level was markedly lower in the Ins+NEFA group than in the Ins group (Fig. 2a) . Ins stimulated AKT phosphorylation in muscle as expected, but the increment was less pronounced during Ins +NEFA infusion, indicating lipid-induced insulin resistance (Fig. 2b) . Antioxidant infusion in the Ins+NEFA+NAC group completely prevented NEFA-induced alterations (Fig. 2a, b) .
Skeletal muscle mitochondrial ROS generation, superoxide production and GSSG-GSH levels
No effects of insulin per se were observed on ROS generation at the mitochondrial level (Fig. 3a-c) or through potential nonmitochondrial sources NADPH oxidase and cyclooxygenase (Fig. 3d) . Ins, however, enhanced muscle superoxide production selectively through the xanthine oxidase pathway (Fig. 3d) . The above effect was associated with an increase in the oxidised-to-reduced glutathione (GSSG/GSH) ratio (Fig. 4c) . Muscle mitochondrial ROS generation was markedly higher in the Ins+NEFA group compared with other experimental groups (Fig. 3a-c) . Compared with controls, a moderate increase in superoxide production through the xanthine oxidase pathway was observed also for the Ins+NEFA group, although it remained markedly lower than the one induced by hyperinsulinaemia per se (Fig. 3d) . Changes in Ins+NEFA were associated with markedly higher GSSG/GSH ratio compared with both control and Ins groups (Fig. 4c) . Concomitant NAC infusion with insulin and NEFA normalised mitochondrial ROS production (Fig. 3a-c) and the GSSG/GSH ratio (Fig. 4c) .
IκBα subunit and NFκB-DNA interaction
Changes in ROS production are reported to be associated with activation of the IκB-NFκB proinflammatory pathway through IκB phosphorylation and subsequent degradation, NFκB nuclear translocation and DNA binding. Also, importantly, these changes reflect upstream reactions that directly impair insulin signalling. In the current study, Ins did not alter either IκB phosphorylated-to-total ratio (P/T ratio; Fig. 5a ) or NFκB-DNA interaction (Fig. 5b) . Conversely, the NEFA-induced higher mitochondrial ROS production was associated with both higher P/T IκB and NFκB-DNA interaction, and these alterations were prevented by antioxidant infusion (Fig. 5a, b) .
Mitochondrial enzyme activities and ATP production
Activities of cytochrome c oxidase and citrate synthase were not statistically significantly different in any group (Fig. 6a,  b) . Mitochondrial ATP production rate was not impaired in the presence of enhanced ROS generation but was, instead, enhanced in both NEFA-infused groups compared with controls ( Fig. 6c) .
Discussion
The major findings of this study are that: (1) hyperinsulinaemia in the high physiological range causes a shift towards a more oxidised redox state in rat skeletal muscle in vivo, selectively associated with enhanced ROS production at the xanthine oxidase level; (2) concomitant NEFA elevation lowers insulin action, in association with enhanced muscle ROS production at the mitochondrial level and IκB-NFκB activation; (3) NEFA-induced metabolic alterations are prevented by antioxidant infusion and are therefore caused by their mitochondrial pro-oxidant effects with IκB-NFκB involvement; (4) acute changes in muscle mitochondrial ROS production, redox state and insulin signalling are not associated with impaired tissue mitochondrial function under the current experimental conditions. The current study introduces the concept that prooxidative modulation of the muscle redox state is a physiological effect of insulin in vivo. Insulin had been reported to enhance the generation of ROS in adipose and liver cells in vitro [1, 2] , with involvement of NADPH oxidase and no negative impact on insulin signalling [1, 2] . The current data show that pro-oxidant insulin-induced changes in superoxide production and redox state are, however, not associated with proinflammatory changes in skeletal muscle of lean animals in the absence of concomitant NEFA elevation. These findings are therefore consistent with previous reports indicating that insulin-induced oxidative stress per se has no major negative metabolic effects and does not activate major insulin-desensitising metabolic pathways in non-muscle tissues [1] [2] [3] [4] . Under the current conditions, the data also identify xanthine oxidase as a selective non-mitochondrial source mediating insulin-induced superoxide production, and this finding is intriguing as it introduces a novel link between insulin, oxidative stress and the xanthine oxidase pathway. Additional studies should be specifically designed to investigate potential interactions between insulin, xanthine oxidase and insulin signalling in models of chronic oxidative stress characterised by insulin resistance and hyperinsulinaemia.
Fatty acid elevation profoundly modulated muscle insulin effects, leading to lower insulin signalling activation associated with selective enhancement of mitochondrial ROS production, pro-oxidative changes in tissue redox state and activation of the IκB-NFκB proinflammatory pathway. The different metabolic impact of quantitatively different levels of ROS production, such as those observed during insulin infusion with and without NEFA, is consistent with previously reported differential effects of low and high [24] . In addition, the possibility that different sites and pathways of ROS production have different effects on muscle metabolic pathways cannot be excluded. Overall, the data identify a novel cluster of NEFA-induced muscle metabolic alterations in the presence of physiological hyperinsulinaemia. Also importantly, concomitant infusion of the antioxidant ROS scavenger NAC prevented the above changes. This observation provides direct evidence for a causal role of mitochondrial ROS production and oxidative stress in the onset of fatty-acid-induced muscle insulin resistance with involvement of the IκB-NFκB pathway, the activation of which by ROS has been previously reported under different experimental conditions [8] .
It should be pointed out that the current experiments were designed to investigate insulin-fatty acid interactions, and the observed metabolic effects cannot be assumed to extend to conditions of isolated fatty acid elevation. Independent effects of fatty acids on muscle redox state are, however, also supported by in vitro studies [9, 10] . Moreover, the current conditions have direct pathophysiological implications in the postprandial state, when hyperinsulinaemia is associated with variable changes in plasma NEFA concentration depending on meal composition [7, 25] . Fatty acid elevation in our study is indeed comparable with reported peak fatty acid increments following fatty meals in humans [25] , suggesting that elevated fatty acid availability following ingestion of a fatty meal may directly cause muscle oxidative stress and inflammation, leading to acute insulin resistance. Importantly, less pronounced elevations of plasma insulin and NEFA concentrations are also observed in obesity induced by long-term high-fat feeding. A contribution of fatty acids to oxidative stress and inflammation previously reported under the above conditions is suggested by the current results [7, 13, 14] , but the direct investigation of this will require further studies with less pronounced and more sustained fatty acid elevation.
Although the issue is partly controversial, chronic changes in mitochondrial oxidative capacity and function have been proposed to contribute to modulation of muscle insulin action by regulating lipid oxidative use [15, 26] . Oxidative stress and proinflammatory cytokines were also reported to lower markers of muscle mitochondrial content and function in the context of chronic high-fat feeding [13, 14] . The current study, however, demonstrated that acute peak physiological fatty acid elevation does not impair mitochondrial enzyme activities or ATP production, which can instead be enhanced by higher lipid substrate availability even in the presence of enhanced ROS production. While this last finding is consistent with a recent study showing that high ROS production in ageing human skeletal muscle is not associated with impaired mitochondrial respiration [27] , the current results support the view that the onset of insulin resistance is, at least in part, independent of the inhibition of mitochondrial enzyme activities and ATP production capacity [27] .
In summary, the current findings demonstrate that acute insulin elevation in the physiological range induces prooxidative changes in muscle redox state through the nonmitochondrial xanthine oxidase pathway. This novel insulin effect does not, however, appear to lead to major negative metabolic effects in the absence of simultaneous NEFA elevation. On the other hand, further enhancement of ROS production at the mitochondrial level by fatty acid infusion causes muscle and systemic insulin resistance through activation of the IκB-NFκB pathway. These changes could play a key role in the negative impact of NEFA on insulin action following fat ingestion, and potentially in the onset of obesityassociated metabolic alterations. Acute changes in muscle mitochondrial ROS production, redox state and insulin signalling are not associated with impaired tissue mitochondrial function under the current experimental conditions.
